Keywords: MorphoSys, R&D pipekine, MOR103, MOR202, MOR208, Gantenerumab

Germany’s MorphoSys showcases pipeline and technology update at R&D day in London

Article | 26 November 2010

Print This

At an R&D day in London, UK, yesterday, German biotechnology firm MorphoSys (MOR: GR) revealed significant recent developments ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in